Yanagisawa Ken

ヤナギサワケン | Yanagisawa Ken

Affiliation and department：
Job title： Associate Professor
Homepage URL (1)： http://www.jichi.ac.jp/biochem/byotai/ken/yanagisawa.html

Research field (2)： Medical biochemistry , Molecular biology

Research keywords (4)：細胞増殖制御 , contact inhibition , IL-1 receptor family , ST2L

Research theme for competitive and other funds (6)：

Show all

Papers (45)：

Akira Kawashima, Tadayoshi Karasawa, Kenji Tago, Hiroaki Kimura, Ryo Kamata, Fumitake Usui-Kawanishi, Sachiko Watanabe, Satoshi Ohta, Megumi Funakoshi-Tago, Ken Yanagisawa, et al. ARIH2 Ubiquitinates NLRP3 and Negatively Regulates NLRP3 Inflammasome Activation in Macrophages. JOURNAL OF IMMUNOLOGY. 2017. 199. 10. 3614-3622
Kenji Tago, Satoshi Ohta, Masaki Kashiwada, Megumi Funakoshi-Tago, Jitsuhiro Matsugi, Shin-Ichi Tominaga, Ken Yanagisawa. ST2 gene products critically contribute to cellular transformation caused by an oncogenic Ras mutant. Heliyon. 2017. 3. 10. e00436
Kenji Tago, Satoshi Ohta, Megumi Funakoshi-Tago, Chihiro Aoki-Ohmura, Jitsuhiro Matsugi, Shin-ichi Tominaga, Ken Yanagisawa. STAT3 and ERK pathways are involved in cell growth stimulation of the ST2/IL1RL1 promoter. FEBS OPEN BIO. 2017. 7. 2. 293-302
Satoshi Ohta, Kenji Tago, Megumi Funakoshi-Tago, Jitsuhiro Matsugi, Ken Yanagisawa. Intracellular NF-HEV/IL-33 harbors essential roles in Ras-induced cellular transformation by contributing to cyclin D1 protein synthesis. CELLULAR SIGNALLING. 2016. 28. 8. 1025-1036
Megumi Funakoshi-Tago, Kazuhi Okamoto, Rika Izumi, Kenji Tago, Ken Yanagisawa, Yuji Narukawa, Fumiyuld Kiuchi, Tadashi Kasahara, Hiroomi Tamura. Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway. INTERNATIONAL IMMUNOPHARMACOLOGY. 2015. 25. 1. 189-198

ｍore...

MISC (27)：

ｍore...

Professional career (3)：

Association Membership(s) (2)：

日本癌学会 , 日本生化学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page